genetics

Pharma By Kate Sheridan

23andMe’s next challenge: ensuring its customers can get drugs developed with their data

First Opinion By Josephine Johnston

The U.S. must do some heavy lifting to prepare for heritable genome editing

Health By Andrew Joseph

Expert panel lays out guidelines for germline editing, while warning against pursuit of ‘CRISPR babies’

First Opinion By Wolfram Nothaft, Gregory Moore, and Yann Le Cam

Using telehealth to revolutionize the speed of making rare disease diagnoses

In the Lab By Rebecca Robbins

Genomic sequencing to screen newborns raises more false alarms than routine blood tests, study finds

Pharma By Matthew Herper

Cancer drug is the first potential therapy to emerge from 23andMe and GlaxoSmithKline collaboration

In the Lab By Sharon Begley

Gene-editing discovery could point the way toward a ‘holy grail’: cures for mitochondrial diseases

Biotech By Matthew Herper

Two patients die in Audentes gene therapy study, heightening concerns over high-dose treatments

In the Lab By Sharon Begley

In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys

The Readout LOUD By Rebecca Robbins, Damian Garde, and Adam Feuerstein

He speaks at Black churches about genetics — and has some ideas about how to fix his field’s diversity problem

The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Listen: The latest on treating Covid-19, vaccine politics, and diversifying genetics

Health By Rebecca Robbins

23andMe says it’s ‘part of the problem’ on racial inequity. We asked geneticists what the company can do about it

First Opinion By Matthias Evers and Michael Chui

The Bio Revolution is changing business and society

Health By Rebecca Robbins

Hospital records hold valuable Covid-19 data. Making it usable is time-consuming work

Health By Rebecca Robbins

23andMe study to recruit sickest Covid-19 patients in bid to unravel role of genetics in disease

Biotech By Sharon Begley

Deluge of genome editing therapies ends research drought for sickle cell disease

Biotech By Elizabeth Cooney

Prominent Broad Institute scientist leaves to lead R&D at Genentech

Health By Rebecca Robbins, Damian Garde, and Adam Feuerstein

‘Science is very much a part of culture’: Siddhartha Mukherjee dives into the history of genetics in a new Ken Burns film

The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Listen: Pandemic exit strategies, how the outbreak affects patients, and Ken Burns takes on DNA

Politics By Rebecca Robbins

Genetic counselors push for permission to hold virtual visits with seniors covered by Medicare

Biotech By Andrew Joseph

Gene and cell therapies continue growth in patients, financing, and costs

In the Lab By Associated Press

In its first use inside the human body, CRISPR genome editing tested as blindness therapy

First Opinion By Ethan J. Weiss

Should ‘broken’ genes be fixed? My daughter changed the way I think about that question

Pharma By Matthew Herper

Roche confirms departure of gene therapy pioneer Kathy High

Health Tech By Rebecca Robbins

FDA names genes that may interact with specific drugs, offering clarity to genetic testing industry